Recent reports have suggested that transvenous cardioversion ofatrial fibrillation is feasible using low-energy shocks and a right atriumcoronary sinus electrode configuration. We evaluated in a prospective studythe efficacy and safety of low-energy internal cardioversion of atrialfibrillation in 104 consecutive patients. Sixty-two patients presented withchronic atrial fibrillation (group I), 16 had paroxysmal atrial fibrillation(group II), and 26 had an induced atrial fibrillation episode (group III).The mean duration of the presenting episode of atrial fibrillation was 9± 19 months for group I, 4 ± 2 days for group II, and 18± 7 minutes for group III. Atrial defibrillation was performed usingtwo intracardiac catheters: one was placed in the right atrium (cathode) andthe other in the coronary sinus or in the left branch of the pulmonaryartery (anode). The catheters were connected to a customized externaldefibrillator capable of delivering 3/3-ms biphasic waveform shocks with avoltage programmable between 10 and 400 volts. The shocks were synchronizedto the R wave. Sinus rhythm was restored in 44 of the 62 patients in group I(70%), in 12 of the 16 patients in group II (75%), and in 20of 26 patients in group III (77%). The mean voltage and energyrequired for cardioversion were respectively 300 ± 68 V and 3.5± 1.5 J, for group I, 245 ± 72 V and 2.0 ± 0.9 J forgroup II, and 270 ± 67 V and 2.6 ± 1.2 J for group III. Theleading-edge voltage required for sinus rhythm restoration was significantlyhigher (p < 0.05) in the chronic atrial fibrillation group than in theparoxysmal or induced groups. No proarrhythmic effects ocurred for thedelivered 686 R-wave synchronized shocks. This study of a large group ofpatients confirms and extends the results of previous reports. Such findingsmay have clinical implications for elective cardioversion of atrialfibrillation and the development of an implantable atrial defibrillator.